By Counterforce Health Team in Kesimpta (ofatumumab) —

How to Get Kesimpta (ofatumumab) Covered by Blue Cross Blue Shield of Michigan: Complete Prior Authorization and Appeal Guide

Answer Box: Getting Kesimpta Covered by BCBS Michigan

Kesimpta (ofatumumab) is covered by Blue Cross Blue Shield of Michigan but requires prior authorization with step therapy documentation (typically 2+ failed MS therapies) and safety screening including hepatitis B testing. The fastest path: your neurologist submits PA through the BCBS Michigan provider portal with diagnosis proof, prior treatment failures, and required lab results. Standard approval takes 15 days (72 hours if urgent). If denied, you have 60-180 days to appeal internally, then 127 days for external review through Michigan DIFS.

Take action today: Call BCBS member services at 1-800-482-5985 to confirm your plan's Kesimpta formulary status and request the prior authorization requirements checklist.

Table of Contents

  1. Coverage Basics: Is Kesimpta Covered?
  2. Prior Authorization Process
  3. Timeline and Status Tracking
  4. Coverage Criteria and Requirements
  5. Costs and Patient Assistance
  6. When Denials Happen: Appeals Process
  7. Renewal Requirements
  8. Specialty Pharmacy Requirements
  9. Troubleshooting Common Issues
  10. Frequently Asked Questions

Coverage Basics: Is Kesimpta Covered?

Blue Cross Blue Shield of Michigan covers Kesimpta (ofatumumab) on most formularies, but it's classified as a specialty medication requiring prior authorization and dispensing through approved specialty pharmacies.

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Doctor must prove medical necessity before coverage BCBS Michigan PA Guidelines BCBS Michigan
Formulary Tier Specialty Tier (Tier 5) - highest copay/coinsurance BCBS Drug Lists BCBS Michigan
Step Therapy Must try 2+ preferred MS drugs first PA Guidelines (above) BCBS Michigan
Quantity Limits 1 pen per 28 days maximum Quantity Limit Program BCBS Michigan
Specialty Pharmacy Must use BCBS-approved specialty pharmacy Member services: 1-800-282-2872 BCBS Michigan

Prior Authorization Process

Step-by-Step: Fastest Path to Approval

  1. Confirm Coverage (Patient): Call BCBS member services at 1-800-482-5985 with your member ID to verify Kesimpta is on your specific plan's formulary.
  2. Complete Safety Screening (Doctor): Order hepatitis B panel (HBsAg, anti-HBc, anti-HBs), quantitative immunoglobulins, CBC, and comprehensive metabolic panel.
  3. Document Step Therapy (Doctor): Gather records showing failure of at least 2 preferred MS therapies (typically 3-6 months each trial).
  4. Submit Prior Authorization (Doctor): Use the BCBS provider portal or Availity system with all required documentation.
  5. Track Status (Both): Monitor approval status through provider portal or by calling 1-800-437-3803 for urgent cases.
  6. Coordinate Specialty Pharmacy (Patient): Once approved, BCBS will transfer your prescription to an approved specialty pharmacy for dispensing.
  7. Start Treatment (Patient): Complete injection training and begin the Kesimpta loading schedule (weeks 0, 1, 2, then monthly).

Required Documentation Checklist

Clinical Information:

  • Multiple sclerosis diagnosis (ICD-10: G35) with evidence of relapsing disease
  • Recent neurology notes documenting disease activity
  • MRI reports showing active lesions or progression

Prior Treatment History:

  • Documentation of at least 2 failed preferred MS therapies
  • Reasons for discontinuation (inefficacy, intolerance, contraindications)
  • Duration of each trial (minimum 3-6 months typically required)

Safety Screening Results:

  • Hepatitis B panel results (must be negative HBsAg)
  • Quantitative immunoglobulin levels
  • Complete blood count and metabolic panel
  • Current vaccination status

Timeline and Status Tracking

Stage Timeline How to Track Contact
Initial PA Review 15 calendar days (72 hours urgent) Provider portal or phone 1-800-437-3803 (urgent)
Additional Information 5-7 days if requested Provider portal notification Provider services
Appeal (Internal) 30 days (preservice); 60 days (standard) Member portal or phone 1-800-482-5985
External Review 56 days standard; 72 hours expedited Michigan DIFS portal 877-999-6442
Tip: Request expedited review if delaying Kesimpta would jeopardize your health. Your doctor must provide written justification for urgent cases.

Coverage Criteria and Requirements

BCBS Michigan follows specific medical criteria for Kesimpta approval:

Diagnosis Requirements

  • Confirmed relapsing multiple sclerosis (CIS, RRMS, or active SPMS)
  • Evidence of recent disease activity (relapses, new MRI lesions, or progression)
  • Documentation from a neurologist

Step Therapy Requirements

You must have tried and failed at least 2 preferred MS therapies, which typically include:

  • Interferon beta preparations (Avonex, Betaseron, Rebif)
  • Glatiramer acetate (Copaxone, Glatopa)
  • Dimethyl fumarate (Tecfidera)
  • Teriflunomide (Aubagio)

Failure criteria include:

  • Lack of efficacy (continued relapses or progression)
  • Intolerance to side effects
  • Medical contraindications

Safety Screening Requirements

Mandatory before approval:

  • Hepatitis B screening: HBsAg, anti-HBc, anti-HBs (must be HBsAg negative)
  • Quantitative serum immunoglobulins
  • Complete blood count with differential
  • Comprehensive metabolic panel
  • Updated immunizations (no live vaccines within 4 weeks of starting)

Contraindications that will result in denial:

  • Active hepatitis B infection (HBsAg positive)
  • Active serious infection
  • Severe immunodeficiency

Costs and Patient Assistance

Insurance Costs

Kesimpta is typically placed on Tier 5 (Specialty) with the highest out-of-pocket costs:

  • Medicare plans: 25-33% coinsurance after $100 specialty deductible
  • Commercial plans: $1,000+ monthly before assistance programs

Money-Saving Options

Novartis Kesimpta CoPay Program:

  • Reduces costs to $0-$5 per month for eligible patients
  • Up to $28,200 annual savings
  • Apply at kesimpta.com/support or call 1-855-KESIMPTA
  • Not available for Medicare patients

Other Assistance Programs:

  • PAN Foundation MS grants (verify current availability)
  • HealthWell Foundation assistance programs
  • Medicare Extra Help for Part D cost reduction

When Denials Happen: Appeals Process

Common Denial Reasons & Solutions

Denial Reason How to Overturn Required Documentation
Insufficient step therapy Provide detailed prior treatment records Prescription records, physician notes, dates of trials
Missing safety labs Submit complete screening results HBV panel, immunoglobulins, CBC, metabolic panel
No evidence of active disease Submit recent MRI or relapse documentation MRI reports, neurology notes, relapse records
Experimental/investigational Cite FDA approval and guidelines FDA labeling, AAN/ECTRIMS guidelines

Michigan Appeals Process

Internal Appeal (First Step):

  • Deadline: 60-180 days from denial
  • Process: Submit appeal letter with medical necessity documentation
  • Timeline: 30-60 days for decision
  • Contact: Use member portal or call 1-800-482-5985

External Review (Final Step):

  • Deadline: 127 days from final internal denial
  • Process: File with Michigan DIFS
  • Timeline: 56 days standard (72 hours expedited)
  • Contact: 877-999-6442 or online portal
From our advocates: We've seen successful appeals when patients included a detailed timeline of their MS progression, clear documentation of why previous treatments failed, and a neurologist's letter explaining why Kesimpta is the most appropriate next step. The key is telling your complete medical story, not just meeting the minimum requirements.

Appeal Letter Template

When writing your appeal, include:

  1. Your story: How MS affects your daily life
  2. Treatment history: Specific drugs tried, duration, and why they failed
  3. Medical necessity: Why Kesimpta is the right choice now
  4. Supporting evidence: Recent MRI, lab results, specialist recommendations

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters and crafting point-by-point rebuttals aligned to each plan's specific requirements.

Renewal Requirements

Kesimpta prior authorization typically requires renewal every 12-24 months. Submit renewal requests 30-45 days before expiration to avoid treatment gaps.

Renewal documentation includes:

  • Treatment response assessment
  • Updated disease status (MRI, clinical evaluation)
  • Continued medical necessity justification
  • Updated safety monitoring results

Specialty Pharmacy Requirements

BCBS Michigan requires Kesimpta to be dispensed through approved specialty pharmacies due to:

  • Cold-chain storage requirements
  • Patient injection training needs
  • Insurance coordination complexity
  • Ongoing clinical support

Common specialty pharmacy partners:

  • Accredo Specialty Pharmacy
  • CVS Specialty
  • Walgreens Specialty Pharmacy

Your prescription will automatically be transferred to a network specialty pharmacy after PA approval. They'll contact you to coordinate delivery and provide injection training.

Troubleshooting Common Issues

Portal Access Problems:

  • Clear browser cache and cookies
  • Try different browser or incognito mode
  • Contact provider support for login issues

Missing Forms:

Delayed Approvals:

  • Call 1-800-437-3803 for urgent cases
  • Request peer-to-peer review if initial denial
  • Consider Kesimpta HCP support for bridge therapy

Frequently Asked Questions

How long does BCBS Michigan prior authorization take for Kesimpta? Standard PA review takes up to 15 calendar days. Urgent cases are processed within 72 hours if medical justification is provided.

What if Kesimpta isn't on my formulary? Request a formulary exception through your doctor. Include medical necessity documentation and evidence that preferred alternatives aren't suitable.

Can I get expedited appeals in Michigan? Yes, Michigan offers expedited external appeals decided within 72 hours if delay would jeopardize your health. Your doctor must provide supporting documentation.

Does step therapy apply if I've tried MS drugs in other states? Yes, treatment history from other states counts toward step therapy requirements. Provide complete medical records to your new neurologist.

What happens if my appeal is denied? After exhausting BCBS internal appeals, you can file for external review with Michigan DIFS within 127 days. This decision is binding on BCBS.

How do I find BCBS-approved specialty pharmacies? Call BCBS member services at 1-800-282-2872 or check your member portal for the current network list.

Can I use manufacturer copay cards with BCBS? The Novartis copay program works with most commercial BCBS plans but excludes Medicare. Check eligibility at kesimpta.com/support.

What if I need Kesimpta while my appeal is pending? Contact Kesimpta patient support about bridge therapy options or temporary assistance programs.

Sources & Further Reading

Disclaimer: This information is for educational purposes and should not replace professional medical or legal advice. Insurance policies vary, and requirements may change. Always verify current information with BCBS Michigan and consult your healthcare provider for medical decisions. For personalized help with complex denials and appeals, Counterforce Health helps patients and clinicians turn insurance denials into targeted, evidence-backed appeals using payer-specific workflows and the latest clinical evidence.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.